#Paris #France #LOG Pharma Packaging #DOW HEALTH+ Eco #Chemical Barrier Packaging

LOG Pharma's Sustainable Solutions Set to Shine at Pharmapack Europe 2026

In the bustling heart of Paris, Pharmapack Europe 2026 is poised to be a pivotal event for the pharmaceutical industry, bringing together innovators and professionals under one roof. Among the key exhibitors is LOG Pharma Primary Packaging, renowned for its commitment to sustainable solutions in pharmaceutical packaging. At this year's event, taking place from January 21 to 22, 2026, LOG will proudly showcase its cutting-edge Eco barrier packaging, underpinned by a vision of sustainability, efficiency, and market competitiveness.

A Step Towards Sustainability

With an increasing focus on environmentally friendly practices across the globe, LOG Pharma's Eco initiative is an answer to the industry’s urgent need for sustainable packaging. Recognizing that pharmaceutical packaging must not only protect but also mitigate environmental impacts, LOG introduces a solution that combines performance with responsible material usage. The Eco barrier has secured a place in the Pharmapack Product Spotlight Gallery, which highlights transformative innovations essential for the industry's progressive future.

Powered by DOW HEALTH+ pharma-grade resins, the Eco packaging is engineered for manufacturers prioritizing moisture and oxygen protection while minimizing resource usage. Notably, this innovative bottle design offers up to a 30% reduction in weight compared to traditional containers, all while ensuring uncompromised barrier performance—vital for safeguarding sensitive formulations.

Cost-Efficiency Meets Environmental Responsibility

In addition to its environmental benefits, LOG's Eco packaging has financial advantages that can not be overlooked. The optimized multilayer structure of these bottles can potentially cut costs by more than 50%. This reduction aids pharmaceutical companies in streamlining their stability planning processes and diminishes their reliance on desiccants and oxygen scavengers. Thus, it accelerates the formulation development cycle, providing significant competitive advantages.

Noam Nahari, VP of Marketing and Business Development at LOG Pharma, emphasizes the importance of such innovations, stating, "Eco embodies our unwavering commitment to practical sustainability. It provides pharmaceutical companies with the necessary protection for their products, allowing them to use less material and reduce their overall environmental footprint. Pharmapack Europe is the ideal platform to showcase what this technology can achieve for the industry."

Addressing Industry Challenges

As pharmaceutical companies navigate the growing complexities of active pharmaceutical ingredients (APIs) that are sensitive to environmental conditions, LOG's innovative solutions are a timely response. Research indicates that around 90% of APIs are susceptible to moisture, underscoring the importance of robust packaging solutions that maintain product integrity over time. LOG offers a comprehensive portfolio that meets the diverse needs of manufacturers dealing with both solid and liquid products in sizes ranging from 15 ml to 1500 ml.

Legacy of LOG Pharma

With over 50 years of dedicated service to the pharmaceutical sector, LOG Pharma Primary Packaging stands at the forefront of packaging innovation. The company operates manufacturing facilities in Israel and Hungary and is part of the larger Perlen Packaging network. To learn more and engage with the LOG team during Pharmapack Europe 2026, interested parties can visit their booth located at Hall 4, Stand B28 or reach out through their official website.

As the event approaches, it is clear that LOG Pharma's commitment to developing sustainable and efficient packaging solutions will play a significant role in shaping the future of pharmaceutical packaging, fostering a greener, more efficient industry for generations to come.